(Q44626222)

4 December 2017

title

Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan (English)

1 reference

4 December 2017

Selective Serotonin Reuptake Inhibitor-induced Rhabdomyolysis Associated with Irinotecan (English)

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

23 March 2024

0 references

1 reference

5

Fadlo Khuri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570350

23 March 2024

author name string

Sarah Richards

1

1 reference

4 December 2017

Joan Giblin

4

1 reference

4 December 2017

Jay N. Umbreit

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570350

23 March 2024

Michael P. Fanucchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14570350

23 March 2024

language of work or name

English

1 reference

inferred from

Southern Medical Journal

publication date

1 October 2003

1 reference

4 December 2017

published in

Southern Medical Journal

1 reference

4 December 2017

volume

96

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1031-1033

1 reference

4 December 2017

1

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

Symptoms and signs of severe citalopram overdose

23 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

23 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations

23 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

Metabolism of CPT-11. Impact on activity.

23 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

Interaction of irinotecan (CPT-11) and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) with human cytochrome P450 enzymes

23 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response

23 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.SMJ.0000084311.35864.D6

23 March 2024

Identifiers

1 reference

4 December 2017

1 reference